Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases

Area of Science:

• Developmental Biology
• Immunology
• Stem Cell Biology

Background:

• Hematopoietic stem and progenitor cell (HSPC) transplantation and cellular immunotherapies face limitations due to challenges in generating functional HSPCs.
• Understanding the developmental triggers for HSPC specification is crucial for advancing these therapeutic approaches.

Purpose of the Study:

• To elucidate the molecular mechanisms regulating hematopoietic specification, focusing on the role of inflammatory pathways in endothelial cells.
• To identify key signaling pathways that prime endothelial cells for the hemogenic endothelium fate switch, a prerequisite for HSPC generation.

Main Methods:

• Utilized genetic and chemical perturbation models in embryonic systems to investigate the function of the Nod1-Ripk2-NF-kB pathway.
• Employed human systems to assess the functional conservation of the identified pathway in definitive hematopoietic differentiation.
• Investigated the role of small Rho GTPases in coordinating pathway activation.

Main Results:

• Early activation of the Nod1-Ripk2-NF-kB pathway in endothelial cells (ECs) is essential for priming them towards definitive hemogenic endothelium (HE).
• Absence of Nod1 or Ripk2 disrupts HE programming and HSPC specification, highlighting their critical roles.
• Small Rho GTPases were identified as key regulators coordinating the activation of this inflammatory pathway.
• Functional conservation of NOD1 was confirmed in human hematopoietic differentiation systems.

Conclusions:

• The RAC1-NOD1-RIPK2-NF-kB axis acts as a critical intrinsic inducer that primes ECs for the HE fate switch and subsequent HSPC specification.
• Targeting this pathway holds promise for generating competent HE, enabling the derivation of patient-specific HSPCs and their derivatives for treating blood disorders.